Frazier Life Sciences Public Fund, L.P. Viridian Therapeutics, Inc.\De (VRDN) insider trading activity
Frazier Life Sciences Public Fund, L.P. is > 10% Shareholder of Viridian Therapeutics, Inc.\DE. Currently has a direct ownership of 1.51 Million shares of VRDN, which is worth approximately $34.2 Million. The most recent transaction as insider was on Sep 23, 2021, when has been sold 200,000 shares (Common Stock) at a price of $11.0 per share, resulting in proceeds of $2,200,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
1.51M
0%
3M change
0%
12M change
Total Value Held
$34.2 Million
FLS
Frazier Life Sciences Public Fund, L.P.
> 10% Shareholder
Seattle, WA